<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>asparaginase</title><link>http://www.unboundmedicine.com/medline/ebm/research/asparaginase</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Vincristine but not imatinib could suppress mesenchymal niche's support to lymphoid leukemic cells.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19925050/full_citation/Vincristine_but_not_imatinib_could_suppress_mesenchymal_niche's_support_to_lymphoid_leukemic_cells_</link><description>Fung KL, Liang RH, Chan GC <br/><span class="title">Vincristine but not imatinib could suppress mesenchymal niche's support to lymphoid leukemic cells. [JOURNAL ARTICLE]</span><br/><span class="source" title="Leukemia &amp; lymphoma">Leuk Lymphoma 2009 Nov 19.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19925050/abstract/Vincristine_but_not_imatinib_could_suppress_mesenchymal_niche's_support_to_lymphoid_leukemic_cells_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19925050/full_citation/Vincristine_but_not_imatinib_could_suppress_mesenchymal_niche's_support_to_lymphoid_leukemic_cells_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19925050/Vincristine_but_not_imatinib_could_suppress_mesenchymal_niche's_support_to_lymphoid_leukemic_cells_">Find Related Articles</a> </description></item><item><title>[Transient hyperlipidemia secondary to treatment with asparaginase and prednisone.]</title><link>http://www.unboundmedicine.com/medline/ebm/record/19879821/full_citation/[Transient_hyperlipidemia_secondary_to_treatment_with_asparaginase_and_prednisone_]</link><description>Losa Frías V, Martín-Sacristán Martín B, Díaz Conejo R, et al. <br/><span class="title">[Transient hyperlipidemia secondary to treatment with asparaginase and prednisone.] [LETTER]</span><br/><span class="source" title="Anales de pediatria (Barcelona, Spain : 2003)">An Pediatr (Barc) 2009 Oct 29.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19879821/full_citation/[Transient_hyperlipidemia_secondary_to_treatment_with_asparaginase_and_prednisone_]">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19879821/[Transient_hyperlipidemia_secondary_to_treatment_with_asparaginase_and_prednisone_]">Find Related Articles</a> </description></item><item><title>Increased levels of tissue factor activity and procoagulant phospholipids during treatment of children with acute lymphoblastic leukaemia.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19874310/full_citation/Increased_levels_of_tissue_factor_activity_and_procoagulant_phospholipids_during_treatment_of_children_with_acute_lymphoblastic_leukaemia_</link><description>Schneider P, Dreden PV, Rousseau A, et al. <br/><span class="title">Increased levels of tissue factor activity and procoagulant phospholipids during treatment of children with acute lymphoblastic leukaemia. [JOURNAL ARTICLE]</span><br/><span class="source" title="British journal of haematology">Br J Haematol 2009 Oct 28.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19874310/abstract/Increased_levels_of_tissue_factor_activity_and_procoagulant_phospholipids_during_treatment_of_children_with_acute_lymphoblastic_leukaemia_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19874310/full_citation/Increased_levels_of_tissue_factor_activity_and_procoagulant_phospholipids_during_treatment_of_children_with_acute_lymphoblastic_leukaemia_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19874310/Increased_levels_of_tissue_factor_activity_and_procoagulant_phospholipids_during_treatment_of_children_with_acute_lymphoblastic_leukaemia_">Find Related Articles</a> </description></item><item><title>The Human Asparaginase-Like Protein 1 hASRGL1is an Ntn Hydrolase with beta-aspartyl Peptidase Activity.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19839645/full_citation/The_Human_Asparaginase_Like_Protein_1_hASRGL1is_an_Ntn_Hydrolase_with_beta_aspartyl_Peptidase_Activity_</link><description>Cantor JR, Stone EM, Chantranupong L, et al. <br/><span class="title">The Human Asparaginase-Like Protein 1 hASRGL1is an Ntn Hydrolase with beta-aspartyl Peptidase Activity. [JOURNAL ARTICLE]</span><br/><span class="source" title="Biochemistry">Biochemistry 2009 Oct 19.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19839645/abstract/The_Human_Asparaginase_Like_Protein_1_hASRGL1is_an_Ntn_Hydrolase_with_beta_aspartyl_Peptidase_Activity_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19839645/full_citation/The_Human_Asparaginase_Like_Protein_1_hASRGL1is_an_Ntn_Hydrolase_with_beta_aspartyl_Peptidase_Activity_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19839645/The_Human_Asparaginase_Like_Protein_1_hASRGL1is_an_Ntn_Hydrolase_with_beta_aspartyl_Peptidase_Activity_">Find Related Articles</a> </description></item><item><title>Effect of L-asparaginase on acrylamide mitigation in a fried-dough pastry model.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19824015/full_citation/Effect_of_L_asparaginase_on_acrylamide_mitigation_in_a_fried_dough_pastry_model_</link><description>Kukurová K, Morales FJ, Bednáriková A, et al. <br/><span class="title">Effect of L-asparaginase on acrylamide mitigation in a fried-dough pastry model. [JOURNAL ARTICLE]</span><br/><span class="source" title="Molecular nutrition &amp; food research">Mol Nutr Food Res 2009 Oct 12.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19824015/abstract/Effect_of_L_asparaginase_on_acrylamide_mitigation_in_a_fried_dough_pastry_model_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19824015/full_citation/Effect_of_L_asparaginase_on_acrylamide_mitigation_in_a_fried_dough_pastry_model_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19824015/Effect_of_L_asparaginase_on_acrylamide_mitigation_in_a_fried_dough_pastry_model_">Find Related Articles</a> </description></item><item><title>The impact of prophylactic fresh frozen plasma and cryoprecipitate on the incidence of CNS thrombosis and hemorrhage in children with acute lymphoblastic leukemia receiving asparaginase.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19822902/full_citation/The_impact_of_prophylactic_fresh_frozen_plasma_and_cryoprecipitate_on_the_incidence_of_CNS_thrombosis_and_hemorrhage_in_children_with_acute_lymphoblastic_leukemia_receiving_asparaginase_</link><description>Abbott LS, Deevska M, Fernandez CV, et al. <br/><span class="title">The impact of prophylactic fresh frozen plasma and cryoprecipitate on the incidence of CNS thrombosis and hemorrhage in children with acute lymphoblastic leukemia receiving asparaginase. [JOURNAL ARTICLE]</span><br/><span class="source" title="Blood">Blood 2009 Oct 12.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19822902/abstract/The_impact_of_prophylactic_fresh_frozen_plasma_and_cryoprecipitate_on_the_incidence_of_CNS_thrombosis_and_hemorrhage_in_children_with_acute_lymphoblastic_leukemia_receiving_asparaginase_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19822902/full_citation/The_impact_of_prophylactic_fresh_frozen_plasma_and_cryoprecipitate_on_the_incidence_of_CNS_thrombosis_and_hemorrhage_in_children_with_acute_lymphoblastic_leukemia_receiving_asparaginase_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19822902/The_impact_of_prophylactic_fresh_frozen_plasma_and_cryoprecipitate_on_the_incidence_of_CNS_thrombosis_and_hemorrhage_in_children_with_acute_lymphoblastic_leukemia_receiving_asparaginase_">Find Related Articles</a> </description></item><item><title>A population pharmacokinetic model for pegylated-asparaginase in children.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19821822/full_citation/A_population_pharmacokinetic_model_for_pegylated_asparaginase_in_children_</link><description>Hempel G, Müller HJ, Lanvers-Kaminsky C, et al. <br/><span class="title">A population pharmacokinetic model for pegylated-asparaginase in children. [JOURNAL ARTICLE]</span><br/><span class="source" title="British journal of haematology">Br J Haematol 2009 Oct 11.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19821822/abstract/A_population_pharmacokinetic_model_for_pegylated_asparaginase_in_children_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19821822/full_citation/A_population_pharmacokinetic_model_for_pegylated_asparaginase_in_children_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19821822/A_population_pharmacokinetic_model_for_pegylated_asparaginase_in_children_">Find Related Articles</a> </description></item><item><title>Effect of L-Asparaginase Combined with Vincristine and Prednisolone on Acute Myeloblastic Leukemia (M0) Associated with Non-Hodgkin Lymphoma.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19816010/full_citation/Effect_of_L_Asparaginase_Combined_with_Vincristine_and_Prednisolone_on_Acute_Myeloblastic_Leukemia__M0__Associated_with_Non_Hodgkin_Lymphoma_</link><description>Horikoshi A, Takei K, Iriyama N, et al. <br/><span class="title">Effect of L-Asparaginase Combined with Vincristine and Prednisolone on Acute Myeloblastic Leukemia (M0) Associated with Non-Hodgkin Lymphoma. [JOURNAL ARTICLE]</span><br/><span class="source" title="Acta haematologica">Acta Haematol 2009 Oct 7; 122(1):54-57.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19816010/abstract/Effect_of_L_Asparaginase_Combined_with_Vincristine_and_Prednisolone_on_Acute_Myeloblastic_Leukemia__M0__Associated_with_Non_Hodgkin_Lymphoma_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19816010/full_citation/Effect_of_L_Asparaginase_Combined_with_Vincristine_and_Prednisolone_on_Acute_Myeloblastic_Leukemia__M0__Associated_with_Non_Hodgkin_Lymphoma_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19816010/Effect_of_L_Asparaginase_Combined_with_Vincristine_and_Prednisolone_on_Acute_Myeloblastic_Leukemia__M0__Associated_with_Non_Hodgkin_Lymphoma_">Find Related Articles</a> </description></item><item><title>Reversible posterior leukoencephalopathy syndrome in childhood: report of nine cases and review of the literature.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19809787/full_citation/Reversible_posterior_leukoencephalopathy_syndrome_in_childhood:_report_of_nine_cases_and_review_of_the_literature_</link><description>Gümüş H, Per H, Kumandaş S, et al. <br/><span class="title">Reversible posterior leukoencephalopathy syndrome in childhood: report of nine cases and review of the literature. [JOURNAL ARTICLE]</span><br/><span class="source" title="Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology">Neurol Sci 2009 Oct 7.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19809787/abstract/Reversible_posterior_leukoencephalopathy_syndrome_in_childhood:_report_of_nine_cases_and_review_of_the_literature_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19809787/full_citation/Reversible_posterior_leukoencephalopathy_syndrome_in_childhood:_report_of_nine_cases_and_review_of_the_literature_">Full Citation</a></description></item><item><title>Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19805690/full_citation/Risk_of_relapse_of_childhood_acute_lymphoblastic_leukemia_is_predicted_by_flow_cytometric_measurement_of_residual_disease_on_day_15_bone_marrow_</link><description>Basso G, Veltroni M, Valsecchi MG, et al. <br/><span class="title">Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="Journal of clinical oncology : official journal of the American Society of Clinical Oncology">J Clin Oncol 2009 Nov 1; 27(31):5168-74.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19805690/abstract/Risk_of_relapse_of_childhood_acute_lymphoblastic_leukemia_is_predicted_by_flow_cytometric_measurement_of_residual_disease_on_day_15_bone_marrow_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19805690/full_citation/Risk_of_relapse_of_childhood_acute_lymphoblastic_leukemia_is_predicted_by_flow_cytometric_measurement_of_residual_disease_on_day_15_bone_marrow_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19805690/Risk_of_relapse_of_childhood_acute_lymphoblastic_leukemia_is_predicted_by_flow_cytometric_measurement_of_residual_disease_on_day_15_bone_marrow_">Find Related Articles</a> </description></item></channel></rss>